Peter Devlin

Biography

Peter Devlin has served as a member of our board of directors since April 2016. From August 2009 to September 2014, Mr. Devlin was the chief commercial officer at Insulet Corporation, a manufacturer of diabetes insulin device products, where he was responsible for the company’s worldwide commercial operations. Prior to joining Insulet, Mr. Devlin held several leadership roles at Abbott Laboratories, Inc. From February 2008 to July 2009, he served as divisional vice president of Abbott’s Global Strategic Marketing in the diabetes care unit, prior to which he served as general manager, hospital & government in the diabetes care unit from December 2006 to February 2008, and prior to which he served as director of Abbott’s Canadian diabetes unit from September 2003 to December 2006.

Research Interest

 Diabetes